(2R,6r)-2,6-Dimethylmorpholine is a chiral, bicyclic amine compound featuring a morpholine ring substituted with two methyl groups at the 2- and 6-positions. It is a versatile chiral building block and a key intermediate in organic synthesis, particularly valued for its rigid, three-dimensional structure and basic nitrogen atom. Its primary and most significant application is in the pharmaceutical industry as a crucial intermediate for the synthesis of active pharmaceutical ingredients (APIs). It serves as a core structural motif in the development of various therapeutic agents. Notably, it is a key chiral synthon in the synthesis of Gefapixant (MK-7264), a P2X3 receptor antagonist investigated for the treatment of refractory chronic cough. Its stereochemistry is essential for the biological activity of the final drug molecule. Beyond its specific use in Gefapixant, this compound exemplifies a valuable chiral amine and heterocyclic scaffold used in medicinal chemistry to modulate the physicochemical and pharmacological properties of drug candidates. It is commercially available from suppliers specializing in fine chemicals and advanced pharmaceutical intermediates.